Facility rendering of new Orca Bio site in Sacramento, CA
September 8, 2022 08:54 AM EDTUpdated 03:27 PM
Cell/Gene Tx
Manufacturing

Or­ca Bio looks to in­crease its cell ther­a­py man­u­fac­tur­ing ca­pac­i­ty with a new fa­cil­i­ty in Sacra­men­to

Tyler Patchen

News Reporter

While Or­ca Bio has net­ted some ma­jor mile­stones, such as a $192 mil­lion Se­ries D and a re­gen­er­a­tive med­i­cine ad­vanced ther­a­py (RMAT) des­ig­na­tion from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times